Free Trial

LifeMD Q4 2023 Earnings Report

LifeMD logo
$5.45 -0.15 (-2.68%)
As of 04:00 PM Eastern

LifeMD EPS Results

Actual EPS
-$0.12
Consensus EPS
-$0.14
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A

LifeMD Revenue Results

Actual Revenue
$44.86 million
Expected Revenue
$40.65 million
Beat/Miss
Beat by +$4.21 million
YoY Revenue Growth
N/A

LifeMD Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Remove Ads

LifeMD Earnings Headlines

LifeMD management to meet with Truist
New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
Lake Street Keeps Their Buy Rating on LifeMD (LFMD)
LifeMD, Inc. (LFMD) Q4 2024 Earnings Call Transcript
LifeMD Reports Fourth Quarter 2024 Results
See More LifeMD Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like LifeMD? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LifeMD and other key companies, straight to your email.

About LifeMD

LifeMD (NASDAQ:LFMD) operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

View LifeMD Profile

More Earnings Resources from MarketBeat